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Abstract
Mouse apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like editing complex 3 (mA3), an intracellular antiviral
factor, has 2 allelic variations that are linked with different susceptibilities to beta- and gammaretrovirus infections among
various mouse strains. In virus-resistant C57BL/6 (B6) mice, mA3 transcripts are more abundant than those in susceptible
BALB/c mice both in the spleen and bone marrow. These strains of mice also express mA3 transcripts with different splicing
patterns: B6 mice preferentially express exon 5-deficient (D5) mA3 mRNA, while BALB/c mice produce exon 5-containing
full-length mA3 mRNA as the major transcript. Although the protein product of the D5 mRNA exerts stronger antiretroviral
activities than the full-length protein, how exon 5 affects mA3 antiviral activity, as well as the genetic mechanisms
regulating exon 5 inclusion into the mA3 transcripts, remains largely uncharacterized. Here we show that mA3 exon 5 is
indeed a functional element that influences protein synthesis at a post-transcriptional level. We further employed in vitro
splicing assays using genomic DNA clones to identify two critical polymorphisms affecting the inclusion of exon 5 into mA3
transcripts: the number of TCCT repeats upstream of exon 5 and the single nucleotide polymorphism within exon 5 located
12 bases upstream of the exon 5/intron 5 boundary. Distribution of the above polymorphisms among different Mus species
indicates that the inclusion of exon 5 into mA3 mRNA is a relatively recent event in the evolution of mice. The widespread
geographic distribution of this exon 5-including genetic variant suggests that in some Mus populations the cost of
maintaining an effective but mutagenic enzyme may outweigh its antiviral function.
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Introduction
The family of apolipoprotein B mRNA-editing enzyme catalytic
polypeptide-like editing complex 3 (APOBEC3) proteins consists
of cytidine deaminases that function as cellular restriction factors
against various exogenous and endogenous viruses [1–17]. Seven
APOBEC3 paralogues have been identified on human chromo-
some 22, while only a single copy of the Apobec3 gene is found in
the mouse genome [10,18,19]. Among the human APOBEC3
enzymes, APOBEC3G (hA3G) is the best characterized member
and is known to inhibit HIV-1 replication when the virus lacks the
functional accessory protein, viral infectivity factor (Vif) [reviewed
in 20]. In the absence of Vif, hA3G is incorporated into newly
generated virions budding from virus-producing cells and exhibits
its antiviral effect in subsequently infected cells. Thus, during
reverse transcription in the target cells, the virion-incorporated
hA3G catalyzes C-to-U deamination on the minus strand of
nascent viral DNA, resulting in G-to-A mutations on the plus
strand of the double-stranded viral DNA, which can be
detrimental to viral replication [7,9,10,21,22]. In addition, a
deaminase-independent antiviral mechanism exerted by hA3G has
also been reported [23,24].
In contrast to its human counterparts, mouse APOBEC3 (mA3)
restricts HIV-1 regardless of the presence of Vif, as well as mouse
mammary tumor virus (MMTV), ecotropic murine leukemia
viruses (MuLVs), Friend MuLV (F-MuLV) and Moloney MuLV
(M-MuLV), along with endogenous mouse retroviruses including
the AKR ecotropic virus (AKV) [5,25–30]. This suggests that
APOBEC3 enzymes protect host genomes from the retroviruses
they commonly encounter, although some retroviruses, like HIV-
1, have evolved to counter the intracellular restriction mechanisms
of their natural hosts.
Friend virus (FV) is an acutely leukemogenic retroviral complex
composed of replication-competent F-MuLV and replication
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FV-induced disease development differ among various inbred
strains of mice, and these are controlled by several host factors
that either directly affect FV replication or influence host
immune responses to the viral antigens [31,32]. We and others
have reported that the mouse Apobec3 locus is polymorphic, and
its genotypes are associated with the levels of viremia after F-
MuLV or FV inoculation [26,27]. Mice of the prototypic FV-
resistant strains C57BL/6 (B6) and C57BL/10 exhibit restricted
replication of F-MuLV and earlier production of FV-neutraliz-
ing antibodies, while FV-susceptible BALB/c and A strains are
less restrictive of F-MuLV replication and show delayed
production of neutralizing antibodies, all of which are linked
with Apobec3 genotypes [26,27,33,34], although the production
of neutralizing antibodies is also influenced by genotypes at the
major histocompatibility complex and the Tnfrsf13c loci, the
latter of which encode the receptor for B-cell activating factor
belonging to the tumor necrosis factor family [31–33,35].
Mouse APOBEC3 and hA3G contain two cytidine deaminase
domains (CDDs), each harboring the conserved zinc-coordinating
motif; however, deaminase activity is exerted only by the N-
terminal CDD of mA3 and the C-terminal CDD of hA3G [36].
We showed that the increased efficiency of B6 mA3 in inhibiting
F-MuLV replication is associated with differences in the primary
amino acid sequence within the active N-terminal CDD [27]; the
functional importance of these residues was further implicated by
the demonstration that they have been under positive selection in
Mus [37]. In addition to the above sequence differences in the
protein-coding regions, efficient virus restriction is also associated
with higher levels of mA3 transcripts in FV-resistant B6 than in
-susceptible BALB/c mice [27,29,38,39]. This enhanced tran-
scription was linked with the presence of the long terminal repeat
(LTR) of an endogenized xenotropic MuLV in the B6, but not in
the BALB/c, Apobec3 locus [37]. A third factor associated with
virus resistance is the presence or absence of exon 5, which
encodes a 33-amino acid segment separating the C-terminal and
N-terminal CDDs [27]. The mA3 isoform of the FV-resistant
strains of mice lacks exon 5, while the predominant transcript in
FV-susceptible mice is the exon 5-containing isoform [27,29,37].
Genetic sequences controlling mA3 splicing have not been
identified, although it has been pointed out that polymorphisms
between the B6 and BALB/c Apobec3 alleles at the end of intron 4
include a putative splice acceptor site and possible mRNA branch
selection site structures [38]. It has also not been shown whether
the well-confirmed differences in transcript levels result in altered
expression levels of mA3 protein in FV-resistant and -susceptible
strains of mice.
In the present report, we show that mA3 protein is indeed more
abundant in B6 than in BALB/c mice. This difference is due in
part to more efficient translation of the exon 5-deficient message.
We further show extensive functional evidence that two distinct
polymorphisms within the Apobec3 locus regulate exon 5 inclusion
during its splicing: the previously predicted [38] TCCT repeat
numbers in intron 4 and a newly identified single nucleotide
polymorphism (SNP) within exon 5. We also describe the linkage
between these splicing regulatory sequences in wild mouse species,
their acquisition in Mus evolution, and their distribution in wild
mouse populations.
Results
APOBEC3 expression is higher in B6 than in BALB/c
spleens at both transcriptional and protein levels
It has been reported that mA3 mRNA expression is higher in
B6 than in BALB/c mice, and the mA3 transcripts detected in B6
mice are predominantly the exon 5-lacking D5 isoform, while the
majority of mA3 transcripts in BALB/c mice contain exon 5 (5+)
[27,29,38]. To more accurately describe the above quantitative
differences in mA3 transcripts, we performed two types of PCR
analyses with two different sets of specific primers (Figure 1A). The
primer set c–d, which is the same as the one previously used [27],
detected both the 5+ and D5 transcripts in reverse-transcription
PCR (RT-PCR) assays; however, mA3 transcripts were barely
detectable after 30 cycles of amplification in BALB/c mice while
the D5 transcript was readily detectable in B6 mice (Figure 1B).
After 35 cycles of amplification, both the 5+ and D5 transcripts
became detectable in BALB/c mice, although the 5+ mRNA was
more abundant. Quantitative real-time PCR (qPCR) assays
revealed mA3 expression levels that were approximately 18-times
higher in B6 than in BALB/c spleens, although the difference in
transcript lengths might have influenced the efficiencies of
amplification in the real-time PCR reactions. To more precisely
quantify the mA3 transcripts, we utilized the second primer set, a–
b, which generates amplicons of the same size from both alleles
(Figure 1A). The qPCR assay performed by using this latter primer
set clearly demonstrated that B6 mice expressed .7-times higher
amounts of mA3 transcript than BALB/c mice did (Figure 1C),
consistent with the previous report [27]. The normalization of
mA3 mRNA levels with TATA box-binding protein or GAPDH
transcripts instead of b-actin gave similar results (data not shown).
Protein levels of mA3 in the above prototypic FV-resistant and
-susceptible strains of mice were also compared. The spleen lysate
from the mA3-knockout mice [40] was used as a negative control.
In B6 spleens, an immunoreactive protein corresponding to D5
mA3 was detected as a prominent band, but the higher molecular
weight 5+ mA3 was also faintly detectable (Figure 1D), even
though the 5+ message was barely detectable by RT-PCR in the
present study (Figure 1B) and in the previous reports [27,29]. On
the other hand, only the 5+ mA3 protein was detected, with a
much lower intensity, in BALB/c spleens. The immunoblotting
assays thus demonstrated that the level of total mA3 protein
Author Summary
Susceptibility to acutely leukemogenic Friend virus (FV)
retrovirus infection varies among different mouse strains
and is governed by several genetic factors, one of which is
allelic variations at the mouse Apobec3 locus. FV-resistant
C57BL/6 (B6) mice express higher amounts of Apobec3
transcripts than susceptible BALB/c mice. We previously
showed that the differences in N-terminal amino acid
sequences between B6 and BALB/c APOBEC3 proteins
partly account for the distinct antiretroviral activities. In
addition, B6 and BALB/c mice express major Apobec3
transcripts of different sizes: the exon 5-lacking and the
full-length transcripts, respectively. Here we asked if exon
5 has any role in the antiviral activity of mouse APOBEC3
and found that the presence of this exon resulted in a
profound decrease in the efficiency of protein synthesis
without affecting the mRNA expression levels. We also
identified two genomic polymorphisms that control the
inclusion of exon 5 into the Apobec3 message: the number
of TCCT repeats in intron 4 and a single nucleotide
polymorphism within exon 5. The distribution of these
functional polymorphisms among Mus species and wild
mouse populations indicates that the exon 5 inclusion
occurred recently in Mus evolution, and the full-length
variant may have selective advantages in some mouse
populations.
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PLoS Pathogens | www.plospathogens.org 2 January 2012 | Volume 8 | Issue 1 | e1002478Figure 1. Expression of mA3 transcripts and protein in the spleens of B6 and BALB/c mice. (A) Schematic representation of the mouse
APOBEC3 exon composition. The exons are indicated by numbers and their relative sizes are depicted. The arrows indicate the locations of the PCR
primers used in the following experiments. (B and C) RT-RCR and quantitative real-time PCR (qPCR) analyses showing splicing patterns and quantities
of mA3 mRNA in B6 and BALB/c spleen cells. The primers utilized were c-d for assays shown in (B) and a–b for those in (C). 5+, exon 5-containing mA3;
D5, mA3 lacking exon 5. Actin was used as an internal control. Quantitative real-time PCR data show averages of three reaction wells and SD. (D)
Immunoblot detection of mA3 protein expressed in mouse spleen cells. The spleen cell extracts were tested for their total protein content by
Bradford assays and the same amount of protein was loaded in each lane. Anti-mouse APOBEC3 NT antibody reactive with an N-terminal epitope was
first pre-absorbed with the spleen lysate prepared from an mA3-knockout (KO) mouse, and was used as the primary antibody. Mouse actin was used
as a loading control. Three independent experiments were done for all assays, and the results were consistent with the representative ones shown
here.
doi:10.1371/journal.ppat.1002478.g001
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BALB/c mice.
Effects of exon 5 inclusion on mA3 protein expression
The mA3 expression data shown in Figure 1 indicate that levels
of mA3 protein expression roughly correlate with the correspond-
ing transcript levels in mice with different Apobec3 alleles. However,
we previously observed that even when FLAG-tagged mA3 was
expressed under the control of the cytomegalovirus (CMV)
promoter, the levels of expression of the 5+ mA3 protein tended
to be much lower than those of the D5 protein, despite similar
levels of mRNA expression in transfected cells [27]. This implies
that exon 5 might affect either the efficiency of mA3 translation or
protein stability. To evaluate these possibilities, 5+ and D5 mA3
expression plasmids were constructed with either B6- or BALB/c-
derived mA3 cDNA (Figure 2A). The mA3 cDNA were fused with
a FLAG tag at their N-terminus and the transcription was driven
by the CMV promoter. After transfection of 293T cells with either
one of the FLAG-tagged expression constructs, we quantified mA3
transcripts by qPCR and mA3 protein by immunoblotting
(Figure 2, B–D). Based on the co-expressed luciferase activities,
similar transfection efficiencies for the 5+ and D5 plasmids were
confirmed, and the data from the qPCR showed that the 5+ mA3
transcript was more highly expressed than the D5 mRNA for both
alleles. Nevertheless, the expression levels of the 5+ mA3 protein
were lower compared to those of the D5 counterpart regardless of
the allelic differences, although B6 D5 protein was expressed more
abundantly than BALB/c D5 (Figure 2, B and C). These results
indicate that the inclusion of exon 5 does not compromise mA3
mRNA expression, but decreases the steady-state levels of mA3
proteins for both allelic variants.
Exon 5 inclusion does not affect mA3 protein stability but
influences its translation
As higher mRNA levels of the 5+ mA3 resulted in lower protein
levels in comparison with those for the D5 isoform in transfected
cells, we next examined the steps at which the synthesis or
degradation of mA3 protein was affected by the presence of exon
5. To this end, we transfected 293T cells with an expression
plasmid harboring the 5+ or D5 mA3 cDNA, and cycloheximide
was added to stop protein synthesis. The inhibitor of nuclear
factor-kB, IkBa, was utilized as a control, as this protein is known
to be in the process of constant degradation and regeneration
under serum-containing culture conditions [41]. As expected,
immunodetectable IkBa decreased upon cycloheximide treatment,
while the solvent alone did not affect the protein content
(Figure 3A). On the other hand, mA3 expressed in the same cells
did not exhibit any reduction upon cycloheximide treatment
regardless of the presence or absence of exon 5. Further, the D5
protein was again detected at higher levels than the 5+ protein.
These results support the conclusion that the effect of exon 5
inclusion in reducing the amount of expressed mA3 protein is not
due to accelerated protein degradation.
We next utilized an in vitro transcription and translation
procedure to determine if exon 5 affects the translation of mA3
(Figure 3B). When the 5+ or D5 mA3 templates were added to the
in vitro transcription and translation reaction, similar amounts of
each transcript were detected by RT-PCR assays both at 30 min
and 60 min after the beginning of incubation. However, the
tempos of appearance and amounts of the 5+ mA3 protein were
different from those of the D5 counterpart: a large amount of the
D5 protein was detected at as early as 30 min after the beginning
of incubation, while the 5+ mA3 was undetectable at the same
time-point. The 5+ mA3 protein became detectable after 60 min
of incubation, but its protein level was still markedly lower than
that of the D5 counterpart. These results collectively indicate that
the inclusion of exon 5 modulates the translation efficiency of mA3
rather than its protein degradation.
The TCCT repeat number variation upstream of exon 5 is
partially responsible for exon 5 inclusion into the mA3
transcript
As the inclusion of exon 5 is associated with a reduced level of
mA3 protein, we next attempted to identify genetic polymor-
phisms that affect the splicing patterns of mA3 transcripts in terms
of exon 5 inclusion. One possible allelic difference in the mouse
Apobec3 locus putatively associated with its splicing patterns is the
possible pre-mRNA branch site polymorphisms found in the
intron upstream of exon 5: a T/C SNP that lies within a preferred
branch site sequence, TA(T/C)CAAC, and TCCT repeat
numbers between this and the acceptor site [38]. As described
previously [38], the intron 4 of the BALB/c allele contains a
tandem repeat of the TCCT sequence near the intron 4/exon 5
boundary, while the B6 allele contains only a single TCCT copy,
changing the length of the putative pyrimidine-rich lariat
intermediate. The adjacent T/C SNP at position 741 from the
first nucleotide of exon 4 is in linkage with the TCCT repeat
number. To directly investigate the possible effect of these
polymorphisms, we constructed splicing assay plasmids that
harbor the Apobec3 genomic fragment encompassing exons 4
through 7 from either the B6 or BALB/c allele. The resultant
plasmids were designated B6 exon 4–7 and BALB exon 4–7
(Figure 4). Three mutants of each of these constructs were made
with different combinations of the position 741 T/C SNP and the
TCCT copy number variation as depicted in Figure 4B.
Because of the possible presence of species-specific regulatory
factors, the resultant genomic constructs were transfected into
BALB/3T3 instead of 293T cells along with the luciferase
expression plasmid as a control for transfection efficiency. To
avoid the amplification of the endogenous mA3 message expressed
in BALB/3T3 cells [27], we utilized the primers g and h
(Figure 4B) for RT-PCR assays, which were designed to hybridize
to the T7 promoter and V5 tag regions of the expression vector.
Transfection with the B6 exon 4–7 plasmid resulted in the
expression of only the D5 transcript, while the BALB exon 4–7
generated both the 5+ and D5 transcripts with much higher
intensity of the 5+ one (Figure 4C), reproducing the splicing
patterns observed in B6 and BALB/c spleens, respectively
(Figure 1B). The ratio between the 5+ and D5 transcripts was
reduced in the samples transfected with BALB DTCCT or BALB
C741T DTCCT plasmid harboring only a single copy of TCCT,
which was further confirmed by utilizing the primer i hybridizing
to the sequence within exon 5 along with primer h (Figure 4C).
Quantitative real-time PCR analyses were done by utilizing
another primer (primer j), designed to hybridize with the sequence
within exon 5, and further confirmed reduced levels of the exon 5-
containing message expressed from the modified BALB exon 4–7
constructs lacking the TCCT repeat. These results imply that the
TCCT repeat observed in the BALB/c allele, but not the T/C
substitution at position 741, at least partly facilitates the exon 5
inclusion. The lack of an effect of the T/C SNP within the putative
branch site sequence was further confirmed by the abundant
expression of the 5+ message from the BALB C741T construct.
However, both the 5+ and D5 transcripts were still produced from
the BALB DTCCT plasmid, suggesting that the TCCT repeat
number is not the only determinant controlling the exon 5
inclusion. In fact, despite the presence of the repeated TCCT, B6
+TCCT and B6 T741C +TCCT did not generate the 5+ message,
Polymorphisms Determining APOBEC3 Exon 5 Inclusion
PLoS Pathogens | www.plospathogens.org 4 January 2012 | Volume 8 | Issue 1 | e1002478Figure 2. Protein expression of the full-length and D5 mA3 in transiently transfected 293T cells. (A) Exon 5-containing (5+) and D5 mA3
cDNA were tagged with the FLAG epitope and inserted into the expression vector. The arrows indicate the positions of the PCR primers. The primer
set a-b is the same as shown in Figure 1. (B and C) 293T cells were transfected with pFLAG-CMV2-mA3
d or pFLAG-CMV2-mA3
dD5 in B or with pFLAG-
CMV2-mA3
b or pFLAG-CMV2-mA3
bD5 in C, which express either the 5+ or D5 mA3 cDNA cloned from BALB/c or B6 mice, respectively [27]. A
luciferase-expressing plasmid, pluc, was co-transfected to standardize transfection efficiencies. At 24 hours after transfection, each one-third of the
transfected cells was used for immunoblotting, RNA extraction, and luciferase assays. For immunoblotting, the full-length and D5 mA3 proteins were
detected with the anti-FLAG antibody. Quantitative real-time PCR reactions were carried out with primer set a-b and were normalized with the levels
of actin transcripts expressed in 293T cells. Data shown are averages of three reaction wells and SD. (D) RT-PCR assays were performed with (RT+)o r
without (RT2) reverse transcription to demonstrate specific detection of expected mRNA. Both primer sets e-f and a-b were used to detect mA3
mRNA. NC, negative control transfected with the empty vector, pFLAG-CMV2. RT– samples were included to evaluate the possible contamination of
transfected DNA. Specific amplification of cDNA generated in the presence of RT was observed in the cells transfected with a plasmid expressing the
5+ or D5 mA3 cDNA. Similar results were obtained for the corresponding B6-derived cDNA clones.
doi:10.1371/journal.ppat.1002478.g002
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wild-type BALB exon 4–7 clearly resulted in the generation of the
5+ mRNA. These results indicate that polymorphisms other than
those in intron 4 might play more important roles in determining
exon 5 inclusion into mA3 messages.
A region around the exon 5/intron 5 boundary contains a
major determinant for exon 5 inclusion
As abundant expression of the exon 5-containing message was
found with the BALB C741T but not with the B6 +TCCT
construct, we were prompted to examine other polymorphisms
downstream of intron 4 that might be involved in the splicing of
exon 5. To explore other possible sequence variations required for
exon 5 inclusion, we focused on intron 5, since this region contains
numerous polymorphisms between reported genomic sequences of
different mouse strains (Figure 5A). Splicing assay vectors
harboring the genomic DNA fragment containing exons 5 and 6
along with the entire intron 5, from either the B6 or the BALB/c
allele, were constructed and designated B6 exon 5–6 or BALB
exon 5–6 (Figure 5B). BALB/3T3 cells transfected with the BALB
exon 5–6 plasmid generated the properly spliced product of the
expected size (Figure 5C), indicating that the splice donor site
Figure 3. The presence of exon 5 does not affect protein degradation but exhibits a profound impact on mA3 protein synthesis.
(A) 293T cells were transfected with pFLAG-CMV2-mA3
d or pFLAG-CMV2-mA3
dD5 along with pFLAG-CMV2-GFP, which expresses green fluorescent
protein (GFP) as a loading control. The cells were treated with cycloheximide for the indicated duration to stop protein synthesis and then harvested.
DMSO was used as a solvent control. The FLAG-tagged mA3 and GFP were detected with the anti-FLAG antibody in immunoblotting. Endogenous
IkBa expression was used as a positive control to confirm the effect of cycloheximide. (B) In vitro transcription and translation assays. DNA templates
containing the entire coding region of the BALB/c full-length or D5 mA3 cDNA with the T7 promoter and His-tag sequence were subjected to an in
vitro transcription/translation reaction by incubating for 30 or 60 min. The levels of mA3 protein synthesis and mRNA expression were evaluated by
immunoblotting using the anti-His antibody and RT-PCR using the primer set a-b, respectively. Intensities of protein bands on the immunoblot
membrane and DNA bands after the RT-PCR reaction and electrophoresis were measured by densitometry and are shown below each corresponding
band. *, signals below detection limits.
doi:10.1371/journal.ppat.1002478.g003
Figure 4. The impact of TCCT repeat numbers on exon 5 inclusion in mA3 mRNA splicing. (A) Schematic representation of the genomic
DNA structure of the Apobec3 gene locus. Boxes indicate exons. LTR, the endogenous retroviral LTR inserted into intron 2 in some strains of mice [37].
(B) Insert structures of the plasmids used for the splicing assays. BALB/c exon 4–7 and BALB/c DTCCT plasmids harbored the same DNA fragment
amplified from BALB/c genomic DNA encompassing exons 4 and 7, except that the BALB/c DTCCT contains only a single TCCT quadruplet. B6 exon 4–
7 plasmid harbored the B6 genomic DNA fragment encompassing exons 4 and 7. C741T and T741C indicate a C to T or reciprocal nucleotide
substitution, respectively, within intron 4 at 741-bp downstream from the first nucleotide of exon 4 on the backbone of the BALB/c or B6 exon 4–7
insert. An additional repeat of the TCCT quadruplet was added to the B6 exon 4–6 construct to generate B6 +TCCT. The positions of primers g, h, i,
and j used for RT-PCR assays are indicated with the arrows. (C) The plasmid harboring each insert depicted in (B) was transfected into BALB/3T3 cells,
total RNA was extracted, and RT-PCR reactions were performed with primer pairs g–h and i–h. A portion of the transfected cells were utilized for
luciferase assays to compare transfection efficiencies among the samples. Comparable levels of luciferase activities were observed in all samples in
each experiment (data not shown). The predicted splicing products are schematically indicated on the right side of the panel. Quantitative real-time
PCR assays were performed with primers g and j, and data are shown here by averages of three reaction wells and SD.
doi:10.1371/journal.ppat.1002478.g004
Polymorphisms Determining APOBEC3 Exon 5 Inclusion
PLoS Pathogens | www.plospathogens.org 7 January 2012 | Volume 8 | Issue 1 | e1002478downstream of exon 5 and the acceptor site upstream of exon 6 in
the BALB/c allele are both functional. In contrast, no spliced
product was detectable in cells transfected with the B6 exon 5–6
plasmid despite a higher transfection efficiency. These results
indicate that the B6 allele may not carry a functional splice donor
site at the exon 5/intron 5 boundary, as the splice acceptor site
upstream of exon 6 seems intact and thus can generate a message
corresponding to the mA3 D5 when exon 4 and intron 4 are
included (Figures 4 and 5C).
To narrow down the region affecting the intron 5 splicing, serial
deletion constructs were produced and subjected to the splicing
assay (Figure 5B). The intron 5-D39 is a deletion construct which
lacks the 39 half of intron 5 but retains the 261-bp sequence
adjacent to exon 6 to include the putative acceptor site. The cells
transfected with the BALB intron 5-D39 plasmid produced the
spliced message as efficiently as those transfected with the parental
BALB exon 5–6 construct; however, the B6 intron 5-D39 plasmid
generated a barely detectable band representing spliced message
(Figure 5D). Quantitative real-time PCR assays revealed markedly
lower levels of properly spliced message generated from the B6
intron 5-D39 plasmid compared to that generated from the BALB/
c counterpart. These data show that the 59 half of intron 5 is
Figure 5. The effect of exon 5 and its downstream sequences on mA3 intron 5 splicing. (A) Distributions of sequence polymorphisms in
the intron 5 of the Apobec3 gene locus between the B6 allele [NT_039621] and the Celera database sequence of mixed mouse DNA
[NW_001030577.1]. Shorter horizontal lines below the thick one representing intron 5 indicate regions of sequenced BALB/c genome [DDBJ accession
No. AB646261-AB646265], which show nucleotide sequences identical to corresponding Celera database sequences. Spans of the analyzed regions
are 1–620, 661–1597, 1643–2058, 2759–3443, and 5558–6247 in base numbers starting from the first nucleotide of intron 5. SNP are shown with
vertical lines, single-base indels with arrows, and deletions of $2 bases with triangles. Indels and deletions above the thick horizontal line that
represents intron 5 are deletions in the B6 allele relative to the Celera sequence, while those underneath the horizontal line are deletions in the Celera
sequence relative to the B6 allele sequence. (B) Plasmid constructions for the splicing assays. The exon 5–6 plasmids harbored either the B6 or BALB/c
genomic fragment encompassing exons 5 and 6, including the entire intron 5 of the corresponding allele. Each of the remaining plasmids possessed
a sequentially reduced length of the intron 5 as indicated. The precise size of each PCR-generated 59 fragment included was as follows: 3177bp and
3185bp for B6 and BALB/c intron 5-D39; 2106bp and 2086bp for B6 and BALB/c 200bp intron 5; 1120bp and 1110bp for B6 and BALB/c 1100bp intron
5; and 634bp and 620bp for B6 and BALB/c 600bp intron 5, respectively. The primers g–h are the same as shown in Figure 4. (C) RT-PCR detection of
spliced messages expressed from the B6 and BALB/c exon 5–6 plasmids along with those from the exon 4–7 plasmids as controls. Primers g and h
were used. A lack of expression of the spliced message in cells transfected with the B6 exon 5–6 plasmid was evident. (D and F) Splicing assays using
intron 5 deletion plasmids. The intron 5 fragment included in each plasmid is shown in (B). RT-PCR assays were performed with primers g and h. A
portion of the transfected cells were utilized for luciferase assays to compare transfection efficiencies among the samples as shown in (C).
Comparable levels of luciferase activities were observed in all samples in each experiment (data not shown). Quantitative real-time PCR data show
averages of three reaction wells and SD. (E) Reciprocal chimeras were produced between B6 and BALB/c exon 5–6 by exchanging the cloned genomic
DNA fragment at position 1100 within intron 5. The exact location of the above position 1100 for B6 and BALB/c intron 5 is described in the legend
for (B). RT-PCR detection of spliced messages was performed with primers g and h. A portion of the transfected cells were utilized for luciferase assays
to compare transfection efficiencies.
doi:10.1371/journal.ppat.1002478.g005
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between the B6 and BALB/c alleles. Thus, further deletions
progressively closer to exon 5 were introduced into the intron 5
fragment. As expected, the shorter the included intron 5 fragment,
the more abundant the spliced product generated was, regardless
of the expressed Apobec3 alleles, indicating that the intron length of
the primary transcript influences the splicing efficiency (Figure 5D).
Nevertheless, the spliced product was generated much more
efficiently from the BALB/c allele than from the B6 allele with all
examined construct pairs, despite comparable levels of transfection
efficiency, indicating that each shorter intron fragment still
retained the polymorphism responsible for the inefficient splicing
of the B6 mRNA.
To exclude the possibility that the 39 region of intron 5 and/or
exon 6 from the B6 allele might harbor inhibitory sequences that
interfere with splicing, we constructed chimeras between the
BALB and B6 exon 5–6 plasmids by exchanging the correspond-
ing genomic DNA fragments at approximately position 1100
within intron 5 (Figure 5E). BALB/B6 chimera harboring the 59
donor site sequence from the BALB/c allele and 39 acceptor site
from the B6 allele generated properly spliced mRNA as efficiently
as the BALB exon 5–6 plasmid did, while the reciprocal construct
harboring the B6 donor and BALB/c acceptor sequences did not
(Figure 5E), indicating that there are no inhibitory elements in the
fragment harboring the 39 intron 5 and exon 6 from the B6 allele.
Thus, we continued to narrow down the sequence affecting the
intron 5 splicing toward the 59 end of the genomic constructs.
Even the shortest construct pair, B6 100bp intron 5 and BALB
100bp intron 5, which harbor the 59 intron 5 fragment a mere
100-bp from the exon 5 boundary, still exhibited a readily
discernible difference in the amounts of the spliced messages, and
this was also true for another pair of deletion constructs that
harbor a 100-bp acceptor region fragment of 39 intron 5
(Figure 5F). These results clearly indicate that the region including
exon 5 and the 59 100-bp of intron 5 carries the primary
determinants responsible for the different efficiencies in splicing of
intron 5 shown by the B6 and BALB/c alleles.
A single nucleotide polymorphism within exon 5 is
primarily responsible for exon 5 inclusion
Within the above narrowed-down region of exon 5 and the 59
100 bp of intron 5, there are only 4 SNPs between the B6 and
BALB/c alleles, as previously described [38]: the T/C SNP at 14-
bp downstream from the first nucleotide of exon 5, G/C at 88-bp
downstream from the same first nucleotide, G/C at 153-bp
downstream within intron 5, and A/C at 163-bp downstream
within intron 5 (Figure 6A). We therefore produced a series of
point mutants based on the B6 intron 5–100 (39-100bp) and
BALB/c intron 5–100 (39-100bp) constructs to precisely identify
the critical SNP responsible for the functionalities of the splice
donor site. In the first set of experiments, shown in Figure 6B, each
indicated nucleotide within the BALB/c genomic sequence was
substituted with the corresponding nucleotide found in the B6
allele. The substitution of the C at position 14 to the B6-type T
slightly reduced the amount of the spliced message; more
importantly, however, the similar substitution of C at position 88
to the B6-type G totally abrogated the intron 5 splicing.
Simultaneous substitutions of C to G at position 153 and G to A
at 163 did not affect the generation of the spliced message.
Transfection efficiencies were essentially equivalent for all samples
and even higher than those for the C88G construct as confirmed
by cotransfecting the luciferase expression plasmid (data not
shown). These results indicate that the G/C SNP at position 88 in
exon 5 is most critical for the splice donor function.
In a reciprocal set of experiments, we attempted to alter splicing
of the transcript of the B6 allele by replacing the polymorphic
nucleotides with the BALB/c-types (Figure 6C). When all 4 SNPs
in the B6 intron 5–100 fragment were replaced with those
corresponding to the BALB/c allele, abundant generation of the
spliced message was observed (Figure 6C). A combined substitu-
tion of T to C and G to C at positions 14 and 88, respectively, also
resulted in efficient splicing of intron 5, and a single substitution of
T to C at position 14 alone slightly increased the generation of the
spliced message from the plasmid harboring the truncated intron.
Importantly, a single substitution of G to C at position 88 resulted
in as abundant expression of the spliced message as that observed
with the BALB/c allele. Thus, these results collectively indicate
that the G at position 88 is critical for the exclusion of exon 5,
although the C at position 14 may also play a minor role in the
inclusion of this exon.
Site-directed mutagenesis of the plasmids harboring the
entire intron 5
To determine the association of the above 4 SNPs with splicing
efficiency under more physiological conditions, we further
introduced point mutations into the B6 exon 5–6 plasmid
harboring the entire intron 5 of 6kb in length, and the resultant
plasmids were subjected to the splicing assays (Figure 7A). In
contrast to the result with the B6 100bp intron 5 T14C mutant
(Figure 6C), we could not detect the generation of spliced mRNA
after transfection of the B6 exon 5–6 T14C mutant (Figure 7B).
However, the single substitution at position 88 from the B6-type G
to BALB/c-type C led to readily detectable production of the
spliced mRNA, despite the general inefficiency in splicing of the
full-length intron 5 depicted in Figure 5. Quantitative real-time
PCR assays revealed levels of expression of the exon 5-containing
spliced message from the B6 exon 5–6 G88C mutant that were
about 70% of those expressed from the BALB exon 5–6 plasmid.
Single nucleotide substitutions at two other positions did not result
in a detectable generation of the spliced mRNA from the B6 allele
(Figure 7B). Combined mutations at positions 14 and 88 within
exon 5 on the B6 exon 5–6 construct (B6 exon 5–6 T14C G88C)
and further addition of the nucleotide replacements at positions
153 and 163 also resulted in detectable generation of the spliced
message, but did not noticeably enhance the splicing over what
resulted from the G88C substitution alone (Figure 7C).
Combined effects of the intron 4 TCCT repeat number
and exon 5 G/C SNP on exon 5 inclusion into mA3 mRNA
To further compare the effects of the TCCT repeat number and
exon 5 G/C SNP at position 88, we constructed B6 and BALB
exon 4–7 plasmids that harbored reciprocal substitutions at these
two polymorphic sites (Figure 8). Introduction of an additional
copy of TCCT into the B6 exon 4–7 construct did not result in the
generation of 5+ message, while the combination of the additional
TCCT and G88C substitution resulted in the generation of exon
5-containing message at levels comparable to those expressed from
the BALB exon 4–7 plasmid. On the other hand, a deletion of a
TCCT copy from the BALB exon 4–7 construct resulted in much
reduced expression of the 5+ message, and the combination of
DTCCT and C88G substitution totally abrogated the generation
of exon 5-containing message. Thus, these results clearly
demonstrate that the most critical polymorphism for exon 5
inclusion into the mA3 mRNA is the G/C SNP at position 88
within exon 5, but for the full-level expression of the 5+ mRNA as
observed in BALB/c mice the intron 4 TCCT repeat is also
required.
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PLoS Pathogens | www.plospathogens.org 9 January 2012 | Volume 8 | Issue 1 | e1002478Figure 6. Identification of critical residues for exon 5 inclusion into mA3 mRNA. (A) Polymorphic nucleotides indicated with the shades
were exchanged at the boxed sites between the B6 and BALB/c alleles. The numbers 14, 88, 153, and 163 above the shown nucleotide sequence are
base numbers from the first nucleotide of exon 5. (B and C) The results of splicing assays performed with the plasmids depicted in (A). The predicted
splicing product is shown on the right side of each panel. Band intensities are averages of 3 independent RT-PCR reactions with SD.
doi:10.1371/journal.ppat.1002478.g006
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polymorphism among Mus species
Because the inclusion of exon 5 into mA3 message depends on
the intron 4 TCCT repeat and the exon 5 G/C polymorphism at
position 88 (G/C88), we screened additional inbred strains and
wild mouse species for these sequence variations and for the
presence or absence of exon 5 in the mA3 message. We sequenced
exon 5 and segments of the flanking introns from 39 mice that
represent different taxa or members of the same species trapped in
different geographic locations (Table S1), as well as those from the
inbred laboratory strains B10.A and A/WySn, prototypic strains
with FV-restrictive and -permissive phenotypes [26,27,31,32]. The
complete dataset is shown in Figure S1. Genomic sequencing
showed that A/WySnJ mice share the TCCT duplication and
exon 5 C88 SNP with BALB/c, while B10.A mice are identical to
B6 mice at both sites (Figure 9A); this is consistent with previous
observations on mA3 expression levels and inclusion of exon 5 in
these strains of mice [27]. Among the 39 wild mice, the TCCT
duplication was found in 10 mice that possessed the exon 5 C88
SNP, and all of the 29 other mice with G88 had a single TCCT
copy as representatively shown in Figure 9A. The observed linkage
between the repeated TCCT and C88 is reasonable, as both are
required for efficient expression of 5+ message from the BALB/c
allele (Figures 4, 6, and 8). RNA samples from 23 of the above
mice were typed for the splicing phenotype. The presence or
absence of exon 5 in mA3 mRNA correlated with the above
identified sequence polymorphisms: exon 5 was present only in 7
mice, all of which had the linked TCCT duplication and C88,
consistent with our functional assays. On the other hand, there
were at least 7 discrepancies with respect to exon 5 inclusion and
the C14 SNP confirming that this SNP has no major role in exon 5
splicing.
The coding sequence for exon 5 was present in all 39 Mus DNA
specimens, as well as in rat DNA specimens (GenBank
EDM15775) as described previously [29]. There were frameshift
mutations within exon 5 in M. setulosus and both M. cervicolor
subspecies, all of which lack exon 5 in mA3 mRNA, and the exon
5-containing splice variant was found only in mA3 mRNA of M.
spretus and 3 of the house mouse species (M. domesticus, M. musculus,
M. castaneus) (Figure 9B). The wild mice were also tested for the
presence or absence of another genetic variation associated with
variable expression levels of mA3, the exon 2-associated
xenotropic MuLV LTR insertion [37]. Results indicated that the
presence of this LTR (LTR
+), like the inclusion of exon 5 due to
the above allelic variation (exon 5
+), was introduced into the
Apobec3 locus at about the time of the house mouse radiation
(Figure 9B). These two features are not found together in any
mouse, and the LTR
+ and exon 5
+ variants are both found in mice
classed as M. musculus or M. domesticus, while M. castaneus mice have
both variants as well as the ancestral D5 LTR
2 mA3 type.
To better understand this species distribution, we typed
additional samples of European M. domesticus and M. musculus for
the presence of the LTR and exon 5 (Figure 9C). The geographic
distribution of the trapping sites for these 19 house mice and for
the exon 5
+ M. spretus indicated that the exon 5
+ mA3 was
characteristic of M. domesticus of north Africa and western Europe,
whereas LTR
+ mA3 was found in eastern Europe (P=0.049 by
Fisher’s exact test). Four of the 9 eastern European M. musculus
mice carried the M. domesticus variant, which is consistent with
previous reports that gene flow across the hybrid zone is biased in
the direction from M. domesticus to M. musculus ([42], for example).
Additional samples identified as M. domesticus were trapped in the
Americas (HAF, CL, WSA, PGN2, SC1, BQC, SAF, JJD, PERA;
see Table S1), and these carried either the exon 5
+ mA3 (like M.
domesticus) or the LTR
+ mA3 (like M. musculus); this is likely due to
the fact that Mus are non-native species that were introduced into
the Americas by passive transport, and although generally classed
as M. domesticus, these mice show evidence of hybridization with
other introduced house mouse species [43,44].
Discussion
Polymorphisms in mA3 are responsible for the fact that the B6
and C57BL/10 mouse strains are more restrictive to the
replication of both beta- and gammaretroviruses than the
BALB/c and A strains [25–29]. These differences in mA3 antiviral
activities have been associated with sequence differences in the N-
terminal region of mA3 [27], different levels of its mRNA
expression [27,29,38,39], and the presence or absence of exon 5 in
mA3 mRNA and protein [27], although the relative importance of
these three factors for antiviral activity has not been established. In
the present study, we focused on the role of exon 5 and have
shown that the D5 mRNA directs more efficient mA3 protein
synthesis than the exon 5-containing message. We have also
identified 2 genetic determinants responsible for the inclusion of
this exon into mA3, a TCCT repeat in intron 4 and a C88
substitution in exon 5 relative to the B6 allele. We further showed
that these two determinants were coordinately acquired within the
last 0.5 million years by house mouse species of Mus.
Previous studies have recognized differences in mRNA
expression levels of mA3 between B6 and BALB/c mice
[27,29,38,39]. Higher constitutive expression of mA3 mRNA is
thought to contribute to better antiviral activity as suggested by the
facts that higher levels of protein production result in more
efficient incorporation of mA3 into viral particles [45] and that
lipopolysaccharide (LPS)-induced enhancement of mA3 expres-
sion results in better restriction of MMTV in vivo [46]. It has also
been shown that increased APOBEC3G and APOBEC3F
expression is associated with lower viral load in rhesus macaques
infected with simian immunodeficiency virus [47]. Higher protein
levels of hA3G in CD14
+ monocytes are also associated with HIV-
1-exposed but uninfected status in humans [48]. The increased
level of Apobec3 gene transcription has been associated with the
presence in the B6 allele of an intact MuLV LTR, a sequence
capable of driving enhanced transcription [37]. While increased
levels of the mA3 transcript could be solely responsible for the
presently observed increase in mA3 protein levels in B6 mice
(Figure 1D), it was also reported that, when driven by the same
strong promoter, the B6 mA3 cDNA lacking exon 5 produced
more protein product than the exon 5-containing BALB/c cDNA
and resulted in more efficient incorporation into viral particles
Figure 7. The G88C nucleotide substitution in exon 5 is most critical for exon 5 inclusion into mA3 mRNA. (A) Polymorphic nucleotides
indicated with the shades were exchanged between the B6 and BALB/c alleles at the sites indicated with the boxes. Plasmids used here carry the
entire intron 5 instead of the deleted one used in the experiments shown in Figure 6. (B and C) The results of splicing assays using the plasmids
depicted in panel (A). The predicted splicing product is shown on the right side of each panel. RT-PCR assays were performed with primers g and h. A
portion of the transfected cells were utilized for luciferase assays to compare transfection efficiencies among the samples. Comparable levels of
luciferase activities were observed in all samples in each experiment (data not shown). Quantitative real-time PCR data show averages of three
reaction wells and SD.
doi:10.1371/journal.ppat.1002478.g007
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increased translation was due to the lack of exon 5 in the B6 cDNA
or to the other sequence differences that distinguish the two
Apobec3 alleles [27,37,38]. Here we have clearly shown that the D5
mRNA directs much more efficient protein synthesis than the 5+
mA3 mRNA regardless of other allelic differences (Figures 2 and
Figure 8. Effect of the combination of intron 4 TCCT repeat and exon 5 G/C SNP on exon 5 inclusion into the mA3 transcripts. B6
exon 4–7 + TCCT and BALB/c exon 4–7 DTCCT plasmids, as described in Figure 4, were further modified so that the exon 5 G/C SNP nucleotide at
position 88 was reciprocally exchanged. The resultant plasmids were used for in vitro transcription assays as described for Figures 4–7. RT-PCR assays
were performed with primers g and h. A portion of the transfected cells were utilized for luciferase assays to compare transfection efficiencies among
the samples. Quantitative real-time PCR data show averages of three reaction wells and SD.
doi:10.1371/journal.ppat.1002478.g008
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with preferential generation of the D5 isoform in mRNA splicing
results in much higher mA3 protein levels in B6 in comparison
with BALB/c mice (Figure 1).
The mechanisms by which the presence of exon 5 in the mRNA
interferes with protein synthesis are currently unclear: however,
predictions of the secondary structure for the mA3 mRNA suggest
that the portion encoding exon 5 may form stable stem-loop
structures (Figure S2), which might interfere with efficient
translation. The predicted stem-loop structure is thermodynami-
cally more stable for B6 than for BALB/c exon 5, and this portion
is actually spliced out from the major transcript in B6 mice. It is
Figure 9. Distribution of sequence variations in and around the Apobec3 exon 5 in Mus species and strains. (A) The Apobec3 genomic
sequences of the indicated strains and representative species are shown. The five SNP tested for their effects on exon 5 splicing are indicated with
shaded bars. Also shown are the number of TCCT repeats and typing results indicating the presence or absence of exon 5 (Ex5) in spliced messages
and the presence or absence of an MuLV LTR in intron 2. (B) The phylogenetic tree is a synthetic tree adapted from other sources [66–68]. Species are
grouped into the 4 Mus subgenera and are listed to the right of each branch. Subspecies and stock or inbred line designations are given where
multiple samples of a given species were tested. Red, exon 5
+/MuLV LTR
2; blue, D5/MuLV LTR
+; green, D5/MuLV LTR
2. *, mice tested for exon 5
splicing pattern. All were sequenced across exon 5 (Figure S1); PERA and MOLF sequence information was taken from Okeoma et al. [38]. (C)
Distribution of expression variants of mA3 in mice trapped in Europe. The red line represents the 20 km-wide hybrid zone separating the ranges of M.
domesticus and M. musculus. Symbols representing mA3 allelic variants are placed at trapping sites.
doi:10.1371/journal.ppat.1002478.g009
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mRNA confers a functional advantage to B6 mice through more
efficient translation of the D5 mRNA and resultant higher levels of
mA3 protein expression. It should be noted, however, that
introduction of this exon between the two CDDs does not
physically disrupt the functional domains, as the 5+ product of the
BALB/c allele still exerts deaminase activity and restricts AKV
replication in vitro [29]. The possible effect of this 33-amino acid
exon on interactions between the N-terminal and C-terminal
CDDs and on mA3 oligomerization remains to be elucidated.
Our results also show that the ancestral Mus Apobec3 gene locus
lacked both the MuLV LTR and the functional polymorphisms
that determine exon 5 inclusion (Figure 9). These two genetic
features were acquired independently at about the time of the
house mouse radiation 0.5–1.0 million years ago, and are found in
distinct lineages of wild mice and different inbred strains of
laboratory mice. It should be noted that all 4 house mouse species
originated and diverged from an ancestral population on the
Indian subcontinent that carries many of the alleles found in
peripheral Eurasian populations [49,50]. The observed distribu-
tion of the LTR
+ and exon 5
+ mA3 variants among the house
mouse lineages is consistent with the appearance of these variants
in this ancestral population. It is thus likely that M. domesticus
progenitors carrying the exon 5
+ Apobec3 allele moved west to
north Africa and western Europe, and M. musculus (LTR
+) moved
north to Russia, eastern Europe and north China. M. castaneus,
which carries these two variants as well as the ancestral D5 LTR
2
mA3, migrated east to Thailand and China. Only the ancestral
mA3 type is found in M. molossinus, which is a natural hybrid of M.
musculus and M. castaneus [44], and these Japanese mice presumably
inherited their Apobec3 gene from their M. castaneus progenitors.
Numerous studies indicate that host antiviral factors co-evolve
with the pathogens they restrict, and this ‘‘arms race’’ is
responsible for mutational changes in APOBEC3 in primates
and mice as evidenced by detectable positive selection [37,51].
The acquisition of the MuLV LTR that is associated with
enhanced mA3 transcription in virus-infected mice also makes
sense as an evolutionary adaptation to pathogen infection [37].
Thus, the B6 Apobec3 allele has acquired two advantageous
features that contribute to enhanced retrovirus restriction: high
mRNA expression directed by the intron 2 LTR that is in linkage
with the positively selected, more functional amino acid sequence
in the N-terminal deaminase domain [27,37]. The BALB/c allele,
in contrast, acquired the polymorphisms that direct exon 5
inclusion as shown in the present study, along with coding
sequence polymorphisms associated with lower antiviral activity
[27]. The far-flung distribution of exon 5
+ mA3 throughout
western Europe (Figure 9C) is surprising, because this allele,
having a reduced level of mA3 protein expression with inefficient
restriction of MuLV replication at least in vitro [27], would seem to
be evolutionarily deleterious. The observed distribution of exon 5
+
mA3 suggests either that the exon 5
+ variant provides sufficiently
protective levels of antiviral activity in virus-infected mice and is
therefore not subject to purifying selection, that these particular
mice have not been exposed to significant challenge by mA3-
sensitive pathogens, that this mA3 variant provides some other,
unrecognized selective advantage, or that this allele is tightly linked
to another advantageous polymorphism.
All 4 house mouse species possessing the exon 5
+ genetic
variation carry beta- and gammaretroviruses along with other
retroelements that are subject to APOBEC3 restriction [25–
30,52]. In this regard, although the BALB/c mA3 is less antiviral
than the product of the B6 allele, it does have measurable antiviral
activity [29]. Further, analysis of 54 germline MuLV proviruses of
three envelope types in the sequenced B6 genome demonstrated
evidence of APOBEC3-mediated editing of the polytropic and
modified polytropic, but not the xenotropic, proviruses [30]. The
mA3-edited polytropic and modified polytropic viruses originated
in M. domesticus [52,53], mice that carry the exon 5
+ mA3,
suggesting that this mA3 variant may be effectively antiviral in vivo.
Finally, in mA3-deficient B6 mice, the absence of this protein
differentially affects FV replication depending on target cell types
[54]. As cell type-dependent and pathogen-induced changes in
mA3 expression may differ between mice of the ancestral D5
LTR
2, exon 5
+, and LTR
+ variants, mice with the exon 5
+ Apobec3
allele may still restrict mA3-sensitive pathogens in critical target
cells.
It is also possible that some mA3 polymorphisms have been
selected for reasons other than their antiviral functions, and these
functions may take precedence in mice not threatened with
retrovirus assault. It is unlikely that differences in mA3 expression
levels and/or its amino acid sequence provide a significant
selective advantage in terms of normal development, survival, or
fertility, as Apobec3-knockout mice show no increased propensity
for tumor development or disease, and both male and female
mA3-deficient mice were fertile [40]. On the other hand, the
presence of active cytidine deaminases can have costs that may
become more significant when endogenous and exogenous
retroviral activity is low. Transgenic mice overexpressing mouse
activation-induced deaminase (AID) or rabbit apolipoprotein B
mRNA-editing enzyme catalytic polypeptide 1 (APOBEC1), two
other members of the AID/APOBEC family of cytidine
deaminases, developed neoplastic diseases and showed evidence
of significant editing of various expressed genes [55,56]. This
suggests that when the retroviral threat is low, the consequences of
possessing highly active mutagenic enzymes, like the D5 mA3
expressed in B6 mice, can outweigh their advantages as antiviral
factors. In this regard, it should be noted that infectious MuLV has
not been isolated from European M. domesticus, which carry the less
highly expressed 5+ mA3, whereas the more active Apobec3 alleles
are found in all 3 of the other species of Mus, all of which have
been found to carry infectious MuLVs [57].
Finally, it has also been observed that there is a similarly wide-
spread distribution in humans of a deletion of a genomic segment
harboring the Apobec3b gene locus [58]. At least one copy of this
deletion is present in .40% of humans. The selective advantage of
this genetic variant has not been determined, but its retention may
suggest a possible advantage in reducing the genotoxic activity of
this cytidine deaminase, or alternatively, it may be linked to
positively selected variants in one or more of the 6 linked human
APOBEC3 paralogues [59,60]. Further comparative analyses of
the geographic and species distributions of natural mouse
pathogens and the various mA3 variants may help define
previously unrecognized targets of APOBEC3-mediated restric-
tion and provide further insight into the coevolution of pathogens
and this host restriction factor.
Materials and Methods
Ethics statement
The studies utilizing laboratory animals were carried out in
strict accordance with the Act on Welfare and Management of
Animals of the government of Japan and the Regulations for the
Care and Use of Laboratory Animals of Kinki University. The
protocol was approved by the Institutional Animal Experimenta-
tion Committee of Kinki University School of Medicine (Permit
Number: KAME-19-029). All surgery was performed under
sodium pentobarbital anesthesia, and all efforts were made to
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in compliance with the US Government Principles for the
Utilization and Care of Vertebrate Animals used in Testing,
Research, and Training; the Public Health Service Policy on
Humane Care and Use of Laboratory Animals; The Animal
Welfare Act and amendment laws; the Animal Care Policies of the
USDA; The Guide for the Care and Use of Laboratory Animals
(7th Edition; National Research Council); and the guidelines of the
Committee on the Care and Use of Laboratory Animals under an
NIAID-approved animal study protocol, and all studies and
procedures were reviewed and approved by the Institutional
Animal Care and Use Committee of the NIH (Permit Number:
ASP LMM 1).
Mice and mouse genomic DNA
C57BL/6NCrslc, BALB/cCrslc, and B10A/SgSnslc mice were
purchased from Japan SLC, Inc., Hamamatsu, Japan. Breeding
pairs of A/WySnJ mice were purchased from The Jackson
Laboratory, Bar Harbor, ME. The mA3-deficient strain on the B6
background has been described [27,40]. All laboratory mice were
housed and bred in the Experimental Animal Facilities at Kinki
University School of Medicine under specific pathogen-free
conditions. The isolation of genomic DNA from spleens was
carried out with DNeasy blood and tissue kit (Qiagen, Inc.,
Hilden, Germany) according to the manufacturer’s instructions.
DNA and RNA were separately isolated from animals and cell
lines developed from wild mice and wild mouse-derived breeding
colonies or inbred strains (Table S1). Many wild-derived mice were
obtained from M. Potter (National Cancer Institute, Bethesda,
MD). CAST/Rp mice were obtained from R. Elliott (Roswell Park
Cancer Institute, Buffalo, NY). Cells from some wild mouse species
were obtained from J. Rodgers (Baylor College of Medicine,
Houston, TX) and from J. Hartley, M. Landeror S. Chattopadhyay
(National Institute of Allergy and Infectious Diseases, Bethesda,
MD) [61,62]. M. cervicolor popaeus mice and tissue samples were
obtained from R. Callahan (National Cancer Institute). Mice or
DNA samples of inbred lines of M. castaneus (CAST/EiJ) and M.
molossinus were obtained from The Jackson Laboratory. M. musculus
DNA samples were obtained from S. Chattopadhyay and H. Morse
(NationalInstituteof AllergyandInfectiousDiseases).DNAsamples
from wild-trapped European M. domesticus were provided by M.
Nachman (University of Arizona, Tucson). DNA samples from 5
wild-derived strains (BLG2, NJL, MSM, HMI, PGN2) were
obtained from the National Institute of Genetics, Mishima, Japan.
A set of Nannomys DNAs was obtained from Y. Cole and P.
D’Eustachio (Departments of Biochemistry and Medicine, New
York University, NY); these mice were classed into 4 species on the
basis of skeletal features by J. T. Marshall (Smithsonian Natural
History Museum, Washington, DC). DNA was isolated from
cultured tail biopsies, spleen, or liver by standard protocols, and
RNA was isolated from the spleen or liver using TRI-Reagent
(Molecular Research Center, Cincinnati, OH) or by a guanidine
chloride extraction method [63].
Mouse Apobec3 sequences and the prediction of mRNA
secondary structures
DNA containing the mouse Apobec3 exon 5 and associated
intron sequences was amplified using either one of the following
forward primers: 59-GGACAATGGTGGCAGGCGATTC-39,
59-GCATCTTTGTGGATGGGG-39, and the reverse primer 5-
TCATTCCTCAATGCTCCTCC-39. PCR products were cloned
into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) before sequenc-
ing. The Apobec3 region was amplified from genomic DNA of B6,
BALB/c, B10A, and A/WySnJ mice using the forward primer
59-TTACAAATTTTAGATACCAGGATTCTAAGCTTCAGG-
AG-39 and the reverse primer 59-GTCCTTTATGTGGGTTC-
CAAGGACC-39. PCR products were treated with ExoSAP-IT
(USB, Cleveland, OH) and directly sequenced with the above
reverse primer. To determine the BALB/c genomic sequence of
the Apobec3 intron 5, the BALB exon 5–6 and BALB intron 5-D39
plasmids (Figure 5) were sequenced by using BigDye Terminator
V3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA)
and an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems)
using the following primers: T7 promoter forward, 59- TAATAC-
GACTCACTATAGGG-39; and V5 reverse, 59-CGTAGAATC-
GAGACCGAGGAGAGGGTTAGGGATAGGC-39.
The secondary structure of a portion of the mA3 mRNA exon 5
was predicted with mfold [64,65].
Cell culture and DNA transfection
BALB/3T3 and human 293T cells were cultured in Dulbecco’s
modified Eagle medium supplemented with 10% heat-inactivated
fetalbovineserum(Invitrogen).Thesecellswereseededat1.0610
5/
well in a well of 6-well plates one day prior to transfection. DNA
transfection was performed by using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s protocols. Mouse spleen cells
were harvested as described previously for protein and RNA
extractions [27]. At least three independent transfection experi-
ments were performed in this study and representative results are
shown in the figures.
Plasmid constructions
The expression plasmids, pFLAG-CMV2-mA3
bD5 harboring the
mA3cDNA derived fromtheD5 transcript ofthe B6allele,pFLAG-
CMV2-mA3
d harboring the cDNA derived from the 5+ transcript of
the BALB/c allele, pFLAG-CMV2-mA3
dD5 harboring the cDNA
derived from the D5 transcript of the BALB/c allele, and control
pFLAG-CMV2-GFP have been described [27]. The genomic DNA
encoding the mA3 exon 5 was amplified from B6 genome with the
following primers: 59-ACCTTGCTACATCTCGGTCCCTTC-
CAGC-39 and 59-CTGCCCTCCACCCAGAACCTCGTCTC-
TGG-39. The above pFLAG-CMV2-mA3
bD5 was used as a PCR
template with primers 59-GCGAATGGACCCGCTAAGTGAA-
GAGG-39 and 59-CTCAGAATCTCCTGAAGCTTAGAATCC-
TGG-39 to amplify the linearized plasmid with a gap between exons
4 and 6. The two PCR products above were treated with T4
polynucleotide kinase (TAKARA Bio, Otsu, Japan) and fused by
using the DNALigationKit ver.2.1 (TAKARABio) to constructthe
plasmid pFALG-CMV2-mA3
b, which expresses the 5+ mA3 cDNA
derived from the B6 allele.
B6 or BALB/c genomic fragments harboring exons 4–7 and the
intervening introns were amplified by PCR using either the B6 or
BALB/c genomic DNA as a template and the common primers
59-CACCAATTTAAAAAGTGTTGGAAGAAG-39 and 59-
GTGGGAGGTCCATGACGTCCACCAGGATCCC-39. Each
amplified DNA product was cloned into a pcDNA3.2/V5/GW/
D-TOPO cloning vector (Invitrogen) and designated as B6 or
BALB exon 4–7, respectively. The above B6 or BALB exon 4–7
was used as a template with the primers 59-CACCACCTTGC-
TACATCTCGGTCC-39 and 59-GCAGAGATGCTTGACTC-
GTTGGTTG-39 or 59-CACCACCTTGCTACATCCCGGTC-
C-39 and 59-GCAGAGATGCTTGACTCGTTGGTTG-39, res-
pectively, for the amplification of B6 or BALB/c exons 5 and 6
and the intervening intron 5. Each PCR product was cloned into
the pcDNA3.2/V5/GW/D-TOPO vector and designated as B6
or BALB exon 5–6. The DNA fragments harboring sequentially
deleted Apobec3 intron 5 were prepared by PCR using either one of
the above B6 or BALB exon 5–6 plasmids as a common template
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product was cloned into the pcDNA3.2/V5/GW/D TOPO
vector to generate the expression plasmid shown in Figure 5B.
Reciprocal chimeras between the above B5 and BALB exon 5–6
plasmids were generated by amplifying a linearized plasmid DNA
lacking the 39 intron 5 and exon 6 using primer pair G, and by
amplifying the insert fragment using primer pair H.
Site-directed mutagenesis was performed by employing the
QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA) using the following templates and primers, listed separately in
Table S2: BALB 100bp intron 5 (39-100bp) plasmid was used as a
common template for the preparation of BALB C14T, BALB C88G,
and BALB C153GG163A with primer pairs I, J, K, respectively: B6
100bp intron 5 (39-100bp) plasmid was used as a template to make B6
T14C or B6 G88C with primer pair L or M, respectively. The
resultant B6 T14C plasmid was used as a template with the same
primer pair M employed for the generation of B6 G88C to make B6
T14C G88C. B6 T14C G88C was then used as a template for the
generation of B6 T14C G88C G153C A163G by using primer pair
O. Similarly, the above-used primer pairs were also utilized for the
generation of B6 exon 5–6 T14C, B6 exon 5–6 T14C G88C, and B6
exon 5–6 T14C G88C G153C A163G mutants by using B6 exon 5–
6 as a template. The B6 exon 5–6 plasmidwas alsoused as a template
with primer pairs M, P, and Q for making B6 exon 5–6 G88C, B6
exon 5–6 G153C, and B6 exon 5–6 A163G, respectively.
To make BALB DTCCT, 4 consecutive nucleotides within the
repeat sequence, TCCT, were deleted from the BALB exon 4–7
plasmid by mutagenesis using primer pair R, listed in Table S2.
BALB DTCCT or BALB exon 4–7 plasmid was used as a template
with primer pair S to make BALB C741T DTCCT or BALB
C741T, respectively. To introduce the TCCT sequence by
mutagenesis and make B6+TCCT, B6 exon 4–7 plasmid was
used as a template with primer pair T. B6+TCCT or B6 exon 4–7
was used as a template with primer pair U to generate B6
T741C+TCCT or B6 T741C, respectively. Similarly, the above
produced B6 exon 4–7+TCCT or BALB exon 4–7 DTCCT
plasmid was used as a template and G88C or C88G substitution
was introduced with primer set M or J, respectively.
All resultant plasmids were entirely sequenced by using BigDye
Terminator V3.1 Cycle Sequencing Kit with an ABI PRISM 3100
Genetic Analyzer. In order to normalize the transfection
efficiency, a plasmid expressing the luciferase gene, pluc, based
on the expression vector pGL3 (Promega, Madison, WI), was
utilized. All the primers used in this study were purchased from
Operon Biotechnologies, Tokyo, Japan.
Quantitative real-time PCR assays for endogenous mA3
transcripts
For the quantification of mA3 transcripts in mouse spleens, total
RNA was extracted from each spleen with RNeasy Mini Kit
(Qiagen). The RNA was then subjected to reverse transcription
with PrimeScript RT reagent Kit (TAKARA Bio). Real-time PCR
reactions were carried out with SYBR Premix Ex Taq II
(TAKARA Bio) on an Applied Biosystems 7900HT Fast Real-
Time PCR System (Applied Biosystems) with two different sets of
Apobec3-specific primers: set 1, 59-GTGTTGGAAGAAGTTT-
GTGG-39 (primer a) and 59-CCTGAAGCTTAGAATCCTGG-
39 (primer b); and set 2, 59-TTACAAATTTTAGATACCAG-
GATTCTAAGCTTCAGGAG-39 (primer c) and 59-TTGGTT-
GTAAAACTGCGAGTAAAATTCCTCTTCAC-39 (primer d).
The data were normalized with expression levels of b-actin mRNA
to obtain DCt values, and DDCt values were calculated.
Detection and quantification of the mA3 transcripts and
their splicing products
For the detection of endogenous mA3 transcripts in mouse
spleen cells, the RT products and primer sets used for the real-time
PCR were also utilized for PCR using KOD Dash DNA
polymerase (Toyobo, Osaka, Japan). The PCR products were
separated by 1% agarose gel electrophoresis and detected by
staining with ethidium bromide. For splicing assays, BALB/3T3
cells were transfected with 1 mg of each plasmid harboring a
genomic DNA fragment and 0.5 mgo fp luc to normalize the
transfection efficiency. Total RNA was extracted from the
transfected cells using the RNeasy Mini Kit at 24 hours post-
transfection. The total RNA was treated with DNase I, reverse
transcribed with SuperScript III First Strand Synthesis System
(Invitrogen), and the resultant cDNA was subjected to PCR
detection using KOD Dash DNA polymerase with the following
primers: 59-TAATACGACTCACTATAGGG-39 (primer g) and
59-CGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAG-
GC-39 (primer h), designed to hybridize the T7 promoter and V5
tag regions of the vector, respectively. Primer i, 59-GGTC-
TCCCAGAGACGAGGTTCTG-39, was used to detect only the
exon 5-containing transcript. For real-time PCR quantification of
the mA3 transcripts containing exon 5, primer j (59-GTGGAT-
GAAGAGCTGGAAGGGACCG-39) was used along with the
above primer g. Transcripts containing exon 6 were similarly
quantified by using primer k (59-CAACCAACGAGTCAAG-
CATCTCTGC-39) and the above primer h.
For RT-PCR detection of mA3 mRNA in cells transfected with
an mA3 expression plasmid, the same RT product as was used for
real-time PCR analyses was utilized with the above-described
primer set 1 (a–b). The RT products made by PrimeScript RT
reagent Kit were supposed to be relatively short in length because
a mixture of oligo-dT and random 6-mers were used as primers in
the RT reaction. Thus, in order to detect the full-length and D5
transcripts, the following primers, 59-GGGAATTCGATGG-
GACCATTCTGTCTGGGATGCAGCCATCGC-39 (primer e)
and 59-GGGTCGACTCAAGACATCGGGGGTCCAAGCTG-
TAGGTTTCC-39 (primer f), were used along with newly syn-
thesized RT products generated by the SuperScript III First
Strand Synthesis System (Invitrogen). To quantify the mA3
transcripts in 293T cells transfected with an mA3 expression
plasmid, one-third of the transfected cells were used for total RNA
isolation using the RNeasy Mini Kit at 24 hours after transfection.
The purified RNA was treated with 5 units of DNase I (TAKARA
Bio) for 1 hour at 37uC to digest the transfected DNA and then
reverse transcribed with the PrimeScript RT reagent Kit. The
real-time PCR was performed as described above.
For RT-PCR analyses of mA3 transcripts generated by the in
vitro transcription/translation system, the reaction was stopped by
the addition of lysis buffer included in RNeasy Mini Kit after 30 or
60 min of incubation, and the transcribed products were purified
with the above kit. After the treatment of the purified RNA with
DNase I, the RT-PCR reaction was carried out with the above
primer set 1. After electrophoresis, gel images were recorded with
a FluorChem
TM IS-8900 transilluminator and band intensities
were analyzed with AlphaEase FC Stand Alone software (Alpha
Innotech, San Leandro, CA).
Apobec3 splicing patterns for wild-derived mice were identified
by RT-PCR to amplify a segment of mA3 RNA spanning exon 5
from total RNA using forward primer 59-GGACCATTCTG-
TCTGGGATGCAGCCATCG-39 and reverse primer 59-GG-
TTGTAAAACTGCGAGTAAAATTCC-39.
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Luciferase assays for normalization of transfection efficiencies
were performed by utilizing the Luciferase Assay System
(Promega). The enzymatic activities were measured by Wallac
1420 ARVO
TM MX-2 Multilabel Counter (Perkin Elmer).
Pre-absorption of the antibody
A spleen from an Apobec3 knock-out mouse [40] was
homogenized in 1ml ice-cold phosphate-buffered saline (PBS).
Four ml of ice-cold acetone was added to the homogenate,
mixed, and incubated on ice for 30 min. The lysate was
centrifuged at 10,0006g at 4uC for 10 min. The pellet was
washed with ice-cold acetone once and dried completely at room
temperature to make spleen extract powder. Two mlo fa n t i -
APOBEC3 NT antibody specific for the N-terminal portion of
mA3 (Millipore, Billerica, MA) was added to 0.5ml of KTBT
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM KCl,
1% Triton X-100) containing 10% (w/v) unimmunized sheep
serum as a carrier, into which 3mg of the spleen extract powder
was dissolved. The mixture was incubated overnight at 4uCw i t h
gentle rotation. After centrifugation at 10,0006g at 4uCf o r
10 min, the supernatant was used as a pre-absorbed anti-mA3
antibody.
Immunoblotting
Western blotting analyses were conducted as described
previously [27] with some modifications. Briefly, proteins were
extracted with a lysis buffer (1% Nonidet P-40, 25 mM Tris-HCl,
pH 7.5, 140 mM NaCl, 1 mM EDTA, 10 mM Na4P2O7)
containing protease inhibitors from Complete, Mini, EDTA-free
Protease Inhibitor Cocktail Tablets (Roche Applied Science,
Mannheim, Germany) and a phosphatase inhibitor, PhosSTOP
(Roche Applied Science). Total protein concentrations were
determined by Bradford assay (Nacalai Tesque, Kyoto, Japan)
and the extracts were mixed with sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) sample buffer and
heated at 95uC for 5 min. The proteins were separated by SDS-
PAGE, transferred to Immobilon-P membrane (Millipore), and
the blotted membranes were blocked with 5% (w/v) skim milk
(Wako Pure Chemicals, Osaka, Japan) in Tris-buffered saline with
0.05% Tween 20 (TBST). The blocked membranes were
incubated with the primary antibody at 4uC overnight. Mem-
branes were then washed with TBST and incubated with horse
radish peroxidase (HRP)-conjugated secondary antibody for
2 hours at room temperature, washed again with TBST, and
the bound antibodies were detected using ECL plus reagent (GE
Healthcare, Tokyo, Japan). The images were captured with a
LAS-1000 Plus (Fujifilm, Tokyo, Japan) and the band intensities
evaluated with Image Gauge ver. 3.12 (Fujifilm). A 1/5 dilution of
the above-mentioned pre-absorbed mA3 antibody was made with
IMMUNO SHOT (COSMO BIO, Tokyo, Japan) and was used
as a primary antibody. Anti-FLAG M2 monoclonal antibody
(mAb) (Sigma-Aldrich), anti-IkBa mAb (L35A5) (Cell Signaling
Technology, Beverly, MA), anti-actin antibody (C-11) (Santa
Cruz, CA), and the His-probe (H-15) (Santa Cruz) were diluted at
1:1000 with TBST. HRP-conjugated rabbit anti-mouse IgG
(Zymed, South San Francisco, CA) and HRP-conjugated Goat
anti-rabbit IgG antibodies (Invitrogen) were also diluted at 1:1000
and used as secondary antibodies to detect each appropriate
primary antibody.
Assessment of mA3 protein stability
1.0610
5 of 293T cells were transfected with 0.1 mg of an mA3
expression plasmid, 0.01 mg pFLAG-CMV2-GFP, and 0.1 mgo f
pluc. After 24h, the cells were treated with 10 mg/ml of
cycloheximide or its solvent dimethyl sulfoxide (DMSO) as a
control for 0, 2, or 4 hours. The cells were washed and
resuspended in PBS. One-tenth of the cell suspension was
subjected to luciferase assays to normalize transfection efficiencies,
and the remaining cells were dissolved in the SDS-PAGE sample
buffer. The normalized amount of cell lysates were separated by
SDS-PAGE followed by immunoblotting as described above.
In vitro transcription and translation
The FLAG-mA3 cDNA was amplified with highly proofreading
Pfu Turbo DNA Polymerase (Stratagene) from the plasmids
pFLAG-CMV-mA3
d and pFLAG-CMV-mA3
dD5 [27], with a
forward primer harboring the T7 promoter sequence, 59-
GGATCCTAATACGACTCACTATAGGGAACAGCTGGGA-
TGGGACCATTCTGTCTGGGATGC-39 and a reverse primer
harboring the His-Tag sequence, 59-TCAATGGTGATGGT-
GATGATGAGCAGCAGCAGACATCGGGGGTCCAAGCTG-
TAGG-39. The PCR products were subjected to reactions for in
vitro transcription and translation using TNT T7 Quick for PCR
DNA (Promega) according to the manufacturer’s protocol. Half of
the generated products were mixed with the SDS-PAGE sample
buffer and analyzed by immunoblotting. The remaining products
were used for RNA purification with RNeasy Mini Kit (Qiagen)
followed by RT-PCR to detect mA3 transcripts.
Supporting Information
Figure S1 Nucleotide sequence of the genomic region
encoding mA3 exon 5 and segments of flanking introns
from several laboratory mouse strains and wild mouse
species. Mouse Apobec3 exon 5 and the flanking introns from 39
mice that represent different taxa or members of the same species
trapped in different geographic locations, as well as those from
the inbred laboratory strains BALB/c, B10.A, and A/WySn,
were sequenced and aligned with the corresponding B6 sequence.
The exon 5 and six key polymorphic regions, C/T741 and
TCCT repeat in intron4, C/T14 and C/G88 in exon5, and C/
G153 and A/G163 in intron 5, are indicated. Accession numbers
for all newly obtained sequence data are also provided in this
figure.
(PDF)
Figure S2 Possible stem-loop structures predicted from
the mA3 intron 5 mRNA sequence. The mRNA secondary
structures of exon 5 encoded by the B6 and BALB/c alleles were
predicted by using the mfold [64,65]. Polymorphic nucleotides
within this exon, U/C at position 14 and G/C at position 88, are
indicated.
(PDF)
Table S1 Designations and sources of wild-derived
mice, their cells, and DNA samples.
(PDF)
Table S2 Primers used to generate intron 5 deletion
mutants and chimeras, for exon 5/intron 5 nucleotide
substitutions, and for modification of TCCT repeat and
T/C 741 SNP in intron 4.
(PDF)
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